GILBERT 🫁

The Gilbert Group is a Netherlands-based startup, founded in 2016, with a mission to redefine treatment for lung patients. Their subsidiary companies, Gilbert Innovation, Gilbert Therapeutics, and Gilbert Technologies, are focused on leveraging scientific findings to develop innovative healthcare solutions. The company's proprietary electrospray technology is being utilized to develop the next generation of soft mist inhalers, aiming to improve treatment for patients with challenging lung conditions.

With a recent €4.00M Series A investment secured on 07 June 2023, Gilbert Group attracted a notable group of investors including the Netherlands Enterprise Agency, Delft Enterprises B.V., DeepTechXL, NanoCorp, and the Brabant Startup Fund. This funding injection is expected to support the company's ongoing research and development efforts, as well as further advancements in the field of healthcare technology.

As a spin-off of Delft University of Technology (TU Delft) and operating from the High Tech Campus in Eindhoven, Gilbert Group is strategically positioned within a vibrant technological ecosystem. Their focus on making medical treatment more effective while reducing the burden on healthcare systems demonstrates a commitment to social impact and technological innovation in the Health Care industry.

Their aspiration to harness evolving technological applications created by science to stimulate healthcare improvements aligns with the growing demand for advancements in medical care. With a clear dedication to optimizing healthcare, Gilbert Group appears poised to continue making significant contributions in the field of lung patient treatment and beyond.